Overview

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults

Status:
Completed

Trial end date:
2018-11-07

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the effect of TAK-925 after a single intravenous dose (compared to placebo) on promoting wakefulness as measured by sleep latency on the maintenance of wakefulness (MWT) in sleep-deprived healthy participants.

Phase:

Phase 1

Details

Lead Sponsor:

Takeda

Treatments:

Armodafinil
Modafinil